Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	structural constituent of muscle	NEB MYOM1 MYBPC1	4.85e-05	43	33	3	GO:0008307
GeneOntologyMolecularFunction	ATP-dependent activity	NAV2 MRE11 MACF1 ACSBG2 SMC1A DDX1 CFTR	5.35e-05	614	33	7	GO:0140657
GeneOntologyMolecularFunction	nuclear vitamin D receptor binding	SNW1 MED12	3.99e-04	18	33	2	GO:0042809
GeneOntologyMolecularFunction	ATP hydrolysis activity	NAV2 MACF1 SMC1A DDX1 CFTR	7.32e-04	441	33	5	GO:0016887
GeneOntologyMolecularFunction	ATP-dependent activity, acting on DNA	NAV2 MRE11 DDX1	1.19e-03	127	33	3	GO:0008094
GeneOntologyMolecularFunction	helicase activity	NAV2 MRE11 DDX1	2.23e-03	158	33	3	GO:0004386
GeneOntologyCellularComponent	nuclear cyclin-dependent protein kinase holoenzyme complex	SNW1 MED12	3.87e-04	18	34	2	GO:0019908
GeneOntologyCellularComponent	nuclear chromosome	MRE11 SIN3A ING3 SMC1A	7.41e-04	254	34	4	GO:0000228
GeneOntologyCellularComponent	myosin filament	MYOM1 MYBPC1	7.52e-04	25	34	2	GO:0032982
GeneOntologyCellularComponent	early endosome	PPP1R21 SAMD9L HSD17B6 CFTR SNX8	1.01e-03	481	34	5	GO:0005769
GeneOntologyCellularComponent	M band	MYOM1 MYBPC1	1.16e-03	31	34	2	GO:0031430
GeneOntologyCellularComponent	myofilament	NEB MYOM1	1.24e-03	32	34	2	GO:0036379
HumanPheno	Narrow mouth	SIN3A FGFR2 NEB MED12 B3GAT3 MYBPC1	3.11e-05	234	15	6	HP:0000160
HumanPheno	Cupped ear	SIN3A FGFR2 MED12 BRWD3	3.76e-05	69	15	4	HP:0000378
HumanPheno	Overlapping toe	PPP1R21 SIN3A FGFR2 MED12	4.45e-05	72	15	4	HP:0001845
HumanPheno	Narrow nose	FGFR2 MED12 SMC1A	6.48e-05	28	15	3	HP:0000460
HumanPheno	Abnormal thumb morphology	SIN3A FGFR2 NEB MED12 SMC1A B3GAT3 MYBPC1	7.34e-05	408	15	7	HP:0001172
HumanPheno	Abnormal neurological laboratory findings	PPP1R21 SAMD9L FGFR2 NEB MED12 SMC1A B3GAT3 COQ7 MYBPC1 VPS13A	9.33e-05	1000	15	10	HP:0003129
HumanPheno	Long philtrum	PPP1R21 SIN3A FGFR2 NEB MED12 SMC1A B3GAT3	1.01e-04	429	15	7	HP:0000343
HumanPheno	Flexion contracture	PPP1R21 SIN3A FGFR2 NEB MED12 SMC1A B3GAT3 COQ7 MYBPC1	1.35e-04	817	15	9	HP:0001371
HumanPheno	Joint contracture	PPP1R21 SIN3A FGFR2 NEB MED12 SMC1A B3GAT3 COQ7 MYBPC1	1.73e-04	843	15	9	HP:0034392
HumanPheno	Broad phalanges of the thumb	FGFR2 B3GAT3	2.24e-04	8	15	2	HP:0009651
HumanPheno	Abnormal tendon morphology	PPP1R21 SIN3A FGFR2 NEB MED12 SMC1A B3GAT3 COQ7 MYBPC1	2.33e-04	875	15	9	HP:0100261
HumanPheno	Excessive wrinkled skin	FGFR2 MED12 CFTR	2.38e-04	43	15	3	HP:0007392
Domain	-	NAV2 NLRP9 SAMD9L SMC1A DDX1 CFTR	2.05e-03	746	34	6	3.40.50.300
Domain	P-loop_NTPase	NAV2 NLRP9 SAMD9L SMC1A DDX1 CFTR	3.89e-03	848	34	6	IPR027417
Domain	SDR_fam	HSD17B6 SCP2D1	4.66e-03	56	34	2	IPR002347
Domain	Ig_I-set	FGFR2 MYOM1 MYBPC1	4.92e-03	190	34	3	IPR013098
Domain	I-set	FGFR2 MYOM1 MYBPC1	4.92e-03	190	34	3	PF07679
Domain	CH	NAV2 MACF1	6.23e-03	65	34	2	SM00033
Domain	CH	NAV2 MACF1	7.19e-03	70	34	2	PF00307
Domain	-	NAV2 MACF1	7.39e-03	71	34	2	1.10.418.10
Domain	CH	NAV2 MACF1	7.80e-03	73	34	2	PS50021
Domain	CH-domain	NAV2 MACF1	8.21e-03	75	34	2	IPR001715
Domain	IGc2	FGFR2 MYOM1 MYBPC1	8.83e-03	235	34	3	SM00408
Domain	Ig_sub2	FGFR2 MYOM1 MYBPC1	8.83e-03	235	34	3	IPR003598
Pathway	WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY	NEB MYOM1 MYBPC1	3.99e-05	38	25	3	M39549
Pathway	WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR	MRE11 DDX1	6.31e-05	7	25	2	M39689
Pathway	WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME	MRE11 SMC1A	1.64e-04	11	25	2	M42562
Pubmed	TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation.	MRE11 SIN3A SNW1 MED12 SMC1A DDX1	1.18e-07	220	37	6	35785414
Pubmed	Molecular diversity of myofibrillar proteins: gene regulation and functional significance.	NEB MYOM1 MYBPC1	2.42e-07	12	37	3	8618961
Pubmed	An Oct4-centered protein interaction network in embryonic stem cells.	SIN3A SNW1 ING3 MED12 SMC1A	9.25e-07	167	37	5	20362541
Pubmed	FGFR2 regulates Mre11 expression and double-strand break repair via the MEK-ERK-POU1F1 pathway in breast tumorigenesis.	MRE11 FGFR2	1.10e-06	2	37	2	25788520
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	MRE11 MACF1 SNW1 MAP7 SMC1A DDX1 GULP1	2.36e-06	582	37	7	20467437
Pubmed	Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing.	MRE11 SIN3A SNW1 SMC1A DDX1	9.84e-06	271	37	5	32433965
Pubmed	Cornelia de Lange Syndrome and the link between chromosomal function, DNA repair and developmental gene regulation.	MRE11 SMC1A	1.10e-05	5	37	2	15917200
Pubmed	Artemis and nonhomologous end joining-independent influence of DNA-dependent protein kinase catalytic subunit on chromosome stability.	MRE11 SMC1A	1.10e-05	5	37	2	19015239
Pubmed	A role for DEAD box 1 at DNA double-strand breaks.	MRE11 DDX1	1.10e-05	5	37	2	18710941
Pubmed	The Rad50S allele promotes ATM-dependent DNA damage responses and suppresses ATM deficiency: implications for the Mre11 complex as a DNA damage sensor.	MRE11 SMC1A	1.65e-05	6	37	2	16357220
Pubmed	NBS1 prevents chromatid-type aberrations through ATM-dependent interactions with SMC1.	MRE11 SMC1A	1.65e-05	6	37	2	18763866
Pubmed	ING2 PHD domain links histone H3 lysine 4 methylation to active gene repression.	SIN3A ING3	2.30e-05	7	37	2	16728974
Pubmed	A role for SKIP in EBNA2 activation of CBF1-repressed promoters.	SIN3A SNW1	2.30e-05	7	37	2	10644367
Pubmed	Genome-wide association study of prognosis in advanced non-small cell lung cancer patients receiving platinum-based chemotherapy.	SNW1 CFTR	2.30e-05	7	37	2	22872573
Pubmed	Ubiquitin-assisted phase separation of dishevelled-2 promotes Wnt signalling.	MRE11 SNW1 SNX8 GULP1	2.59e-05	161	37	4	36398662
Pubmed	Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.	MRE11 SIN3A SNW1 SMC1A DDX1	2.61e-05	332	37	5	32786267
Pubmed	The E3 ubiquitin ligase Cul4b promotes CD4+ T cell expansion by aiding the repair of damaged DNA.	MRE11 SMC1A	3.95e-05	9	37	2	33524014
Pubmed	Tropomodulin isoforms regulate thin filament pointed-end capping and skeletal muscle physiology.	NEB MYOM1	4.93e-05	10	37	2	20368620
Pubmed	MDC1 is a mediator of the mammalian DNA damage checkpoint.	MRE11 SMC1A	6.02e-05	11	37	2	12607005
Pubmed	SMC1 is a downstream effector in the ATM/NBS1 branch of the human S-phase checkpoint.	MRE11 SMC1A	6.02e-05	11	37	2	11877377
Pubmed	Multifactorial contributions to an acute DNA damage response by BRCA1/BARD1-containing complexes.	MRE11 SMC1A	7.22e-05	12	37	2	16391231
Pubmed	FBXW7 modulates cellular stress response and metastatic potential through HSF1 post-translational modification.	SIN3A MED12 SNX8	7.98e-05	78	37	3	25720964
Pubmed	A Combinatorial CRISPR-Cas9 Screen Identifies Ifenprodil as an Adjunct to Sorafenib for Liver Cancer Treatment.	FGFR2 CFTR	8.53e-05	13	37	2	34666996
Pubmed	Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.	MRE11 SNW1 ING3 SMC1A	9.05e-05	222	37	4	37071664
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	MACF1 SIN3A SNW1 MED12 SMC1A DDX1	1.38e-04	759	37	6	35915203
Pubmed	Splicing factor Srsf5 deletion disrupts alternative splicing and causes noncompaction of ventricular myocardium.	NEB MYOM1	1.48e-04	17	37	2	34622152
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	MACF1 NEB MYOM1 SMC1A MYBPC1	1.75e-04	497	37	5	23414517
Pubmed	Systematic proteomics of endogenous human cohesin reveals an interaction with diverse splicing factors and RNA-binding proteins required for mitotic progression.	SNW1 MAP7 MED12 SMC1A	1.97e-04	272	37	4	31010829
Pubmed	ATAC and Mediator coactivators form a stable complex and regulate a set of non-coding RNA genes.	SIN3A SNW1 MED12	2.04e-04	107	37	3	20508642
Pubmed	Sin3a regulates epithelial progenitor cell fate during lung development.	SIN3A FGFR2	2.28e-04	21	37	2	28619823
Pubmed	Structural and functional conservation of the NuA4 histone acetyltransferase complex from yeast to humans.	SIN3A ING3	2.75e-04	23	37	2	14966270
Pubmed	Rhox8 homeobox gene ablation leads to rete testis abnormality and male subfertility in mice†.	FGFR2 CFTR	2.99e-04	24	37	2	37471646
Pubmed	EVI1 oncoprotein interacts with a large and complex network of proteins and integrates signals through protein phosphorylation.	MRE11 GOLGA6L1 SMC1A	3.45e-04	128	37	3	23858473
Pubmed	Laser capture microdissection and cDNA array analysis for identification of mouse KIAA/FLJ genes differentially expressed in the embryonic dorsal spinal cord.	NAV2 MACF1	3.80e-04	27	37	2	19026994
Pubmed	Automated yeast two-hybrid screening for nuclear receptor-interacting proteins.	MACF1 SNW1 ING3	3.86e-04	133	37	3	15604093
Pubmed	Cracking the egg: molecular dynamics and evolutionary aspects of the transition from the fully grown oocyte to embryo.	NAV2 NLRP9 FGFR2 UBE2G1	3.92e-04	326	37	4	17015433
Pubmed	BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors.	SIN3A SNW1 ING3	3.95e-04	134	37	3	25452129
Pubmed	Mediator and cohesin connect gene expression and chromatin architecture.	MED12 SMC1A	4.09e-04	28	37	2	20720539
Pubmed	Proteomic identification of the MYST domain histone acetyltransferase TIP60 (HTATIP) as a co-activator of the myeloid transcription factor C/EBPalpha.	MACF1 SMC1A	4.39e-04	29	37	2	18239623
Pubmed	An unexpected role for BAG3 in regulating PARP1 ubiquitination in oxidative stress-related endothelial damage.	SNW1 DDX1	5.02e-04	31	37	2	35066290
Pubmed	TRIM29 regulates the assembly of DNA repair proteins into damaged chromatin.	MRE11 SMC1A	5.02e-04	31	37	2	26095369
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	MACF1 SAMD9L MAP7 MYOM1	5.75e-04	361	37	4	26167880
Pubmed	Gene expression profiling in the developing secondary palate in the absence of Tbx1 function.	FGFR2 MYOM1	6.05e-04	34	37	2	29866044
Pubmed	Hypertrophic Cardiomyopathy Overview	MYOM1 B3GAT3	6.05e-04	34	37	2	20301725
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	MRE11 MACF1 SIN3A SNW1 MAP7 SMC1A DDX1	6.41e-04	1415	37	7	28515276
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	MRE11 SIN3A SNW1 MED12 SMC1A DDX1	6.49e-04	1014	37	6	32416067
Pubmed	Human transcription factor protein interaction networks.	MRE11 SIN3A SNW1 ING3 MAP7 SMC1A DDX1	6.79e-04	1429	37	7	35140242
Pubmed	Proteomic analysis of SRm160-containing complexes reveals a conserved association with cohesin.	SNW1 SMC1A DDX1	7.89e-04	170	37	3	16159877
Pubmed	Prdm16 is required for the maintenance of brown adipocyte identity and function in adult mice.	NEB MYBPC1	7.96e-04	39	37	2	24703692
Pubmed	WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage.	MRE11 SIN3A SMC1A DDX1	7.97e-04	394	37	4	27248496
Pubmed	Prediction of the coding sequences of unidentified human genes. V. The coding sequences of 40 new genes (KIAA0161-KIAA0200) deduced by analysis of cDNA clones from human cell line KG-1.	MED12 SMC1A	8.80e-04	41	37	2	8724849
Pubmed	Cooperative control of striated muscle mass and metabolism by MuRF1 and MuRF2.	NEB MYBPC1	8.80e-04	41	37	2	18157088
Pubmed	Congenital asplenia in mice and humans with mutations in a Pbx/Nkx2-5/p15 module.	MRE11 MACF1 SMC1A	8.87e-04	177	37	3	22560297
Pubmed	ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation.	SIN3A ING3	9.23e-04	42	37	2	16387653
Pubmed	Merkel cell polyomavirus recruits MYCL to the EP400 complex to promote oncogenesis.	SIN3A ING3	9.23e-04	42	37	2	29028833
Pubmed	Transcription factor protein interactomes reveal genetic determinants in heart disease.	SIN3A ING3 SMC1A DDX1	9.33e-04	411	37	4	35182466
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	MRE11 SIN3A SNW1 MED12 SMC1A DDX1	1.01e-03	1103	37	6	34189442
Pubmed	Abnormal Mammary Development in 129:STAT1-Null Mice is Stroma-Dependent.	NEB MYBPC1	1.01e-03	44	37	2	26075897
Interaction	KLHL41 interactions	NEB MYOM1 MYBPC1	1.21e-05	26	35	3	int:KLHL41
Cytoband	15q11.2	GOLGA6L6 GOLGA6L1 GOLGA6L22	3.66e-04	172	37	3	15q11.2
Cytoband	Ensembl 112 genes in cytogenetic band chr15q11	GOLGA6L6 GOLGA6L1 GOLGA6L22	7.19e-04	217	37	3	chr15q11
Cytoband	Ensembl 112 genes in cytogenetic band chr7q31	ING3 CFTR	5.73e-03	140	37	2	chr7q31
GeneFamily	Fibronectin type III domain containing\|I-set domain containing\|Myosin binding proteins	MYOM1 MYBPC1	4.71e-05	8	24	2	658
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	FGFR2 MYOM1 MYBPC1	1.22e-03	161	24	3	593
GeneFamily	Fibronectin type III domain containing	MYOM1 MYBPC1	1.89e-02	160	24	2	555
ToppCell	E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Noncycling_AT2_Precursor\|E16.5-samps / Age Group, Lineage, Cell class and subclass	SAMD9L FGFR2 MAP7 CFTR	7.32e-06	155	36	4	9cad73d0b8ead289e1073d1a2e00bbeb1228308c
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D231\|Adult / Lineage, Cell type, age group and donor	FGFR2 MAP7 HSD17B6 CFTR	1.05e-05	170	36	4	269dee5abca9f6aa079f116f0d8f1d198604d9d4
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NAV2 FGFR2 MAP7 CFTR	1.32e-05	180	36	4	b798a3fa2dd15b68aa4267f665559527043dcc07
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NAV2 FGFR2 MAP7 CFTR	1.44e-05	184	36	4	ab2f06906fc7a9931dfa0864ef506832b07fb93e
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NAV2 FGFR2 MAP7 CFTR	1.47e-05	185	36	4	fefaf227d89f680d6f3e91c4a94e26ab4d0dc6c3
ToppCell	Control-Epithelial_alveolar-AT_2-Differentiating_AT2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NAV2 FGFR2 MAP7 CFTR	1.47e-05	185	36	4	0d2add28ac1f4fa6de7699be009bf8391badaf4c
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_2-AT2_Progenitor\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NAV2 FGFR2 MAP7 CFTR	1.47e-05	185	36	4	929b68b05b7686341329ac756d7df172cb4b810b
ToppCell	COVID-19-Epithelial_cells-Airway_club\|COVID-19 / group, cell type (main and fine annotations)	NAV2 FGFR2 MAP7 CFTR	1.47e-05	185	36	4	cfe6fd73d817e173fe803bc1683c291d9bcb8608
ToppCell	Control-Epithelial-Club\|World / Disease state, Lineage and Cell class	NAV2 FGFR2 MAP7 CFTR	1.50e-05	186	36	4	9798428691408e17ff2af2fe2d1b345f074d67e4
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NAV2 FGFR2 MAP7 CFTR	1.57e-05	188	36	4	4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f
ToppCell	PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	FGFR2 MAP7 CFTR VPS13A	1.57e-05	188	36	4	beb2df2332a46cc81b10e8e29fc9829020111f03
ToppCell	background-Cholangiocytes\|World / Sample and Cell Type and Tumor Cluster (all cells)	FGFR2 SYT13 CFTR GULP1	1.67e-05	191	36	4	99aa8d685767a72bef9f05e7cc8913126a048c39
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	NAV2 FGFR2 MAP7 CFTR	1.67e-05	191	36	4	ca5669bd6f4a17471acae3eb229f845cc2e08efa
ToppCell	Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|World / Lineage, Cell type, age group and donor	NAV2 FGFR2 HSD17B6 CFTR	1.67e-05	191	36	4	d3733c8c4bda70c4390e5601fdda6188a64be944
ToppCell	Epithelial\|World / Lineage, Cell type, age group and donor	NAV2 FGFR2 MAP7 CFTR	1.70e-05	192	36	4	499e8893afea5e6d3371e0bd018f7e86a524d669
ToppCell	background-Cholangiocytes\|background / Sample and Cell Type and Tumor Cluster (all cells)	FGFR2 SYT13 CFTR GULP1	1.74e-05	193	36	4	9152241073dbe02ac2c11d86bec9b5b529196f6e
ToppCell	Fetal_29-31_weeks-Epithelial\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	NAV2 FGFR2 MAP7 CFTR	1.74e-05	193	36	4	a0ca3231992f14abcf1a6129573bace320e89d2a
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAV2 MACF1 SYT13 VPS13A	1.81e-05	195	36	4	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAV2 MACF1 SYT13 VPS13A	1.81e-05	195	36	4	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	NAV2 FGFR2 MAP7 CFTR	1.88e-05	197	36	4	1485933986921ff45669d9b7501c8d17050b3e97
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	NAV2 FGFR2 MAP7 CFTR	1.92e-05	198	36	4	285f729140b1df029c24f6ca1d2438470ac51794
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MACF1 FGFR2 HSD17B6 MYBPC1	2.00e-05	200	36	4	07d942803360e1a1e8e131d6e31c726dd0db1a0b
ToppCell	TCGA-Uterus-Primary_Tumor-Uterine_Carcinoma-Uterine_Carcinosarcoma-4\|TCGA-Uterus / Sample_Type by Project: Shred V9	NEB MYOM1 MYBPC1	1.61e-04	131	36	3	1801611e6b63aa07629e7ccc692f45a7e93c8dd8
ToppCell	COVID-19_Mild-Neu_2\|World / 5 Neutrophil clusters in COVID-19 patients	MRE11 FGFR2 SYT13	1.95e-04	140	36	3	b1429028c52f84127b894b93b55961badcd5246f
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NLRP9 CSMD3 CFTR	2.21e-04	146	36	3	ec1f793409d1a81c0f9323eb3c82ffe01dae0e44
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MAP7 CSMD3 CFTR	2.49e-04	152	36	3	655d47efe0608d729801f1f01668e84c1bc0675f
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	FGFR2 MAP7 HSD17B6	2.84e-04	159	36	3	e6ff9d2bce62bf9ea173af80b688eeb40fa4ea4c
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ING3 CSMD3 GULP1	3.22e-04	166	36	3	3b67064a5149e72f895344d938c64b8ff65247f5
ToppCell	droplet-Lung-nan-21m-Lymphocytic-Proliferating_NK\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MRE11 SIN3A C17orf50	3.22e-04	166	36	3	21ba5fd755c0fb31ada42a1b5d60bede0153323d
ToppCell	wk_20-22-Epithelial-Airway_epithelial_progenitor\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	FGFR2 MAP7 CFTR	3.22e-04	166	36	3	fcd0bd70b553789092249806ace324b77bd10481
ToppCell	wk_20-22-Epithelial-Airway_epithelial_progenitor-epi-stalk_late\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	FGFR2 MAP7 CFTR	3.22e-04	166	36	3	b60954e5625743657d0fd9264b738b46e72fd8a6
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_E\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	PPP1R21 NEB MYOM1	3.28e-04	167	36	3	b5d15773be32cd277125fd3b4056a8fefaefa5ec
ToppCell	facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l44-58\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NEB MYOM1 MYBPC1	3.28e-04	167	36	3	d78356bf0c473816dbabaee51984940bd822f84e
ToppCell	droplet-Liver-LIVER_HEPATOCYTES-30m-Lymphocytic\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CSMD3 SYT13 GULP1	3.28e-04	167	36	3	e1b1a952fce27ab9cf16919b290625ff4a75261e
ToppCell	3'-GW_trimst-2-SmallIntestine-Epithelial-Tuft-related\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GCNT3 MYOM1 CFTR	3.28e-04	167	36	3	7cb5b52aaa5b595fe2e97d9e175294ea8d63b165
ToppCell	3'-Distal_airway-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2-Transitional_Club-AT2_L.0.4.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NAV2 HSD17B6 CFTR	3.51e-04	171	36	3	d5960b40ad5b87aaa00c93a6b31cdf41cc4f1375
ToppCell	3'-Distal_airway-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NAV2 HSD17B6 CFTR	3.51e-04	171	36	3	fd59ac4a39748840b2ee1c930ea475433ff61485
ToppCell	3'-Distal_airway-Epithelial-Epithelial_transtional-epithelial_cell_of_lung\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NAV2 HSD17B6 CFTR	3.51e-04	171	36	3	d382430e5cdd0f2aac4fc093d8fe8d66efb4629b
ToppCell	3'-Distal_airway-Epithelial-Epithelial_transtional\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NAV2 HSD17B6 CFTR	3.51e-04	171	36	3	4347e6f62c04ea43299893ad4b79719049009a56
ToppCell	COVID-19-Heart-T_cell\|COVID-19 / Disease (COVID-19 only), tissue and cell type	NEB CSMD3 MYBPC1	3.51e-04	171	36	3	b2e753e811a7639956994609f73efcdb62d04f82
ToppCell	3'-GW_trimst-2-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GCNT3 MYOM1 CFTR	3.63e-04	173	36	3	b75353fcbc9f8cdb21d4f10ddbc93a83fd797a3c
ToppCell	droplet-Liver-LIVER_HEPATOCYTES-30m-Lymphocytic-B_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CSMD3 SYT13 GULP1	3.76e-04	175	36	3	59249c9e83952d7277010e7be3c779e26399eb5d
ToppCell	droplet-Lung-21m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MRE11 SIN3A C17orf50	3.76e-04	175	36	3	6751ee4b312d7f87275f2c35e5878cfc3be3ebe3
ToppCell	droplet-Liver-LIVER_HEPATOCYTES-30m-Lymphocytic-B_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CSMD3 SYT13 GULP1	3.76e-04	175	36	3	b35cc1357495f2a03a6500f807c6e6f8c877734d
ToppCell	nucseq-Epithelial-Epithelial_Airway-Secretory/RAS\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FGFR2 CFTR GULP1	3.88e-04	177	36	3	779ba86f53650772755b52460be03f18bb204e55
ToppCell	nucseq-Epithelial-Epithelial_Airway-Secretory/RAS-Secretory\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FGFR2 CFTR GULP1	3.88e-04	177	36	3	0f210cfb61b873c5fd77dc17eadf4d017306500e
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NAV2 SYT13 CFTR	3.95e-04	178	36	3	a0ab20c588e7d43d0320d4779d9ab95c1c86e297
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	NAV2 FGFR2 HSD17B6	4.01e-04	179	36	3	cb38b54261a7af5ee3347e64c8aa880a77ed0763
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	FGFR2 MAP7 CFTR	4.01e-04	179	36	3	815b959ce8721c5ded70c0ca6e318dafc691746e
ToppCell	droplet-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte-type_1_alveolar_epithelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FGFR2 MYOM1 CFTR	4.01e-04	179	36	3	ca70a5518c5a5392e088c103e0cb44aa084f5332
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_2-AT2_Progenitor\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FGFR2 MAP7 CFTR	4.01e-04	179	36	3	7db6b97a1c4c7a163d5da4351ba36ac1785d9d7b
ToppCell	droplet-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FGFR2 MYOM1 CFTR	4.01e-04	179	36	3	c451b074b04eb5d6c575c6abaedda579c6744bbf
ToppCell	LPS_only-Epithelial_alveolar-AT_2-AT2_Progenitor\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FGFR2 MAP7 CFTR	4.15e-04	181	36	3	0513b9e6673ff7bf8e72ba123ca3794b65d10170
ToppCell	Control-Epithelial_cells-Airway_club\|Control / group, cell type (main and fine annotations)	NAV2 FGFR2 CFTR	4.15e-04	181	36	3	c755d23dd9aabc717dc73e2b3fa99a1f751e6507
ToppCell	droplet-Marrow-nan-3m-Hematologic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MACF1 SAMD9L VPS13A	4.21e-04	182	36	3	1710eab3037a87609d21838be2d2d29c3bc36651
ToppCell	COVID-19-kidney-CD-IC-B\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MAP7 CSMD3 CFTR	4.21e-04	182	36	3	ee6a8c356bbbdae55e4ea858337e079491f9f4aa
ToppCell	droplet-Marrow-nan-3m-Hematologic-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MACF1 SAMD9L VPS13A	4.21e-04	182	36	3	e78ba2c5cae480c16a596ce7c3bf2d480becacf4
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NAV2 FGFR2 MAP7	4.21e-04	182	36	3	17ed11a7ea366dd3106400511d5e628d3f1a9c3e
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FGFR2 HSD17B6 CFTR	4.28e-04	183	36	3	6847c1252d6bb105524f812658112517fd351eab
ToppCell	Mild/Remission-B_intermediate-10\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	MACF1 NEB PLXNC1	4.28e-04	183	36	3	278064c9f0582463b83bf156d34e77f60187613b
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NEB CSMD3 CFTR	4.35e-04	184	36	3	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NEB CSMD3 CFTR	4.35e-04	184	36	3	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NEB CSMD3 CFTR	4.35e-04	184	36	3	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	COVID-19-Epithelial_cells-AT2\|COVID-19 / group, cell type (main and fine annotations)	FGFR2 MAP7 CFTR	4.35e-04	184	36	3	369b82f793deab672204558ae4e112cfa5aa9ccc
ToppCell	Control-Epithelial_alveolar-AT_2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NAV2 FGFR2 MAP7	4.35e-04	184	36	3	51e129b3fcc2df083eda05a3afe3717218b1e52b
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-AT2_Progenitor\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NAV2 FGFR2 MAP7	4.35e-04	184	36	3	d0c212a8fbaad24597a84018442b25c61c17ea58
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NAV2 FGFR2 MAP7	4.35e-04	184	36	3	7cc5796557379c3d1db078c1aeda40659c6e401c
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FGFR2 MYBPC1 GULP1	4.35e-04	184	36	3	7d41784eac0935e77d6bc701f20c693adf998730
ToppCell	Control-Epithelial_alveolar\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NAV2 FGFR2 MAP7	4.42e-04	185	36	3	3937e026add96a396122139daf8011cfbc60e75c
ToppCell	facs-BAT-Fat-24m-Epithelial-Epcam+\|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FGFR2 GCNT3 BRWD3	4.49e-04	186	36	3	b18d7398279a2d42414318aeb70514fd402f5a0a
ToppCell	facs-Lung-EPCAM-3m\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAV2 FGFR2 CFTR	4.49e-04	186	36	3	7c4eb769574f9f32753cea1cc38c711dabba88b9
ToppCell	COPD-Epithelial-Club\|World / Disease state, Lineage and Cell class	NAV2 FGFR2 MAP7	4.49e-04	186	36	3	3006f4ab1eaf1eb34c10ca9f7c869603d2d25744
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NAV2 FGFR2 MAP7	4.49e-04	186	36	3	4e94158db52df41d71e67b02b9895a358eebee0f
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NAV2 FGFR2 MAP7	4.49e-04	186	36	3	e83718fabb057100835d3357df407f283d23fe16
ToppCell	Adult-Epithelial-club_cell-D231\|Adult / Lineage, Cell type, age group and donor	FGFR2 CFTR GULP1	4.56e-04	187	36	3	ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86
ToppCell	LPS-antiTNF-Epithelial_alveolar\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NAV2 FGFR2 MAP7	4.56e-04	187	36	3	201ff693e4756ee3e44762885b3a303a77eb535b
ToppCell	Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|World / Lineage, Cell type, age group and donor	MAP7 HSD17B6 CFTR	4.56e-04	187	36	3	81cc8435b2704a9a8287b3f54acaae0f11dd4ac7
ToppCell	3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NEB SYT13 CFTR	4.63e-04	188	36	3	1f912ea015f50570e848259d948a0ba682d64bb4
ToppCell	LPS-IL1RA-Epithelial_alveolar\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NAV2 FGFR2 MAP7	4.63e-04	188	36	3	6164d467b612767ceba15de34176bcc8e8c36ab8
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NAV2 FGFR2 MAP7	4.63e-04	188	36	3	43a0508d2524a5b310e89e9422843dcaab999bc3
ToppCell	human_hepatoblastoma-Tumor_cells-T5\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	NAV2 FGFR2 MAP7	4.63e-04	188	36	3	b070a0667f1ee9b825b267b6c389b7c42fc436f9
ToppCell	COVID-19-Epithelial_cells\|COVID-19 / group, cell type (main and fine annotations)	NAV2 FGFR2 MAP7	4.63e-04	188	36	3	c9cdee6f8d42ee69f5fb335f25084603c511bd29
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	FGFR2 MAP7 CFTR	4.70e-04	189	36	3	7659c7bbd58ee959a159294fb8d17317bbcc5681
ToppCell	(2)_NK/T-(210)_NKT_cell\|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization)	MACF1 SAMD9L FGFR2	4.70e-04	189	36	3	fa72e87e1e8cd7cbddae7b47e19cf90d181820a7
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-skeletal_muscle_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NEB MYOM1 MYBPC1	4.70e-04	189	36	3	d2b008f98739c6af7ee63b643011a240db20e4d8
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D231\|Adult / Lineage, Cell type, age group and donor	FGFR2 MAP7 CFTR	4.70e-04	189	36	3	dab54a52358f66a8a9460cd6089a06c5fa7e7a5d
ToppCell	COVID-19-lung-Secretory\|lung / Disease (COVID-19 only), tissue and cell type	FGFR2 MAP7 CFTR	4.70e-04	189	36	3	84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25
ToppCell	IPF-Epithelial-Club\|IPF / Disease state, Lineage and Cell class	NAV2 FGFR2 CFTR	4.70e-04	189	36	3	f3fcef008ef252b29ac6d567fef27f9acf9cd70f
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-AT2_Progenitor\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NAV2 FGFR2 MAP7	4.70e-04	189	36	3	5f883ef4cc0383142d538ae61f4fb40dfdb8ef18
ToppCell	(2)_NK/T-(21)_NKT_cell\|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization)	MACF1 SAMD9L FGFR2	4.70e-04	189	36	3	b37ad24898a14a4a3b2d6cea2637de2471f76e20
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	FGFR2 MAP7 CFTR	4.78e-04	190	36	3	8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e
ToppCell	Adult-Epithelial-club_cell\|Adult / Lineage, Cell type, age group and donor	FGFR2 CFTR GULP1	4.78e-04	190	36	3	756bff697d30aec56c0ebfca94295f084a15bf37
ToppCell	BL-critical-LOC-Epithelial-Secretory\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	FGFR2 GCNT3 GULP1	4.78e-04	190	36	3	f2abe4bc28e934287e2dcd7b9399d5af78c5c8cf
ToppCell	COVID-19-Epithelial_cells-Airway_goblet\|COVID-19 / group, cell type (main and fine annotations)	FGFR2 MAP7 CFTR	4.78e-04	190	36	3	51ca9ef4df3220487152fcf684147730637c7cc1
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	FGFR2 MAP7 CFTR	4.85e-04	191	36	3	34cc997e4e5c727495f321e6807a84aa124da486
ToppCell	COPD-Epithelial-Club\|COPD / Disease state, Lineage and Cell class	NAV2 FGFR2 MAP7	4.85e-04	191	36	3	c909cf5fa0e6519aa93a47d2c3fcd2ae2163cd8d
ToppCell	3'-GW_trimst-1-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GCNT3 MYOM1 CFTR	4.85e-04	191	36	3	7065728128e37572b87e6b024374796bd2172e92
ToppCell	Children_(3_yrs)-Epithelial\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FGFR2 MAP7 CFTR	4.85e-04	191	36	3	e432c6e1ae82dddf84314ce73d2b7a991630d905
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FGFR2 MAP7 CFTR	4.85e-04	191	36	3	a0332a4ef629510fb313ec119195c44a3f704a80
ToppCell	3'-GW_trimst-1-SmallIntestine-Epithelial-Tuft-related\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GCNT3 MYOM1 CFTR	4.85e-04	191	36	3	7717cf1d99b4451d7145d91367637895f9a2c1c3
Computational	Genes in the cancer module 202.	NEB MYOM1 MYBPC1	3.95e-05	28	26	3	MODULE_202
Computational	Genes in the cancer module 387.	NEB MYOM1 MYBPC1	2.15e-04	49	26	3	MODULE_387
Computational	Genes in the cancer module 201.	NEB MYOM1 MYBPC1	2.28e-04	50	26	3	MODULE_201
Computational	Genes in the cancer module 329.	NEB MYOM1 MYBPC1	2.42e-04	51	26	3	MODULE_329
Drug	Kynurenine, 3-hydroxy (R,S) [2147-61-7]; Down 200; 17.8uM; MCF7; HT_HG-U133A	MACF1 FGFR2 NEB MED12 COQ7	1.13e-05	194	35	5	5641_DN
Drug	Etanidazole [22668-01-5]; Up 200; 18.6uM; HL60; HT_HG-U133A	FGFR2 GCNT3 NEB PLXNC1 COQ7	1.18e-05	196	35	5	2510_UP
Drug	Folic acid [59-30-3]; Down 200; 9uM; PC3; HT_HG-U133A	FGFR2 MAP7 B3GAT3 COQ7 VPS13A	1.27e-05	199	35	5	5844_DN
Disease	stomach carcinoma (is_implicated_in)	MRE11 FGFR2	7.95e-05	12	33	2	DOID:5517 (is_implicated_in)
Disease	Drug habituation	CSMD3 DDX1 CFTR	2.89e-04	115	33	3	C0013170
Disease	Substance-Related Disorders	CSMD3 DDX1 CFTR	2.89e-04	115	33	3	C0236969
Disease	Drug abuse	CSMD3 DDX1 CFTR	2.89e-04	115	33	3	C0013146
Disease	Drug Use Disorders	CSMD3 DDX1 CFTR	2.89e-04	115	33	3	C0013222
Disease	Drug Dependence	CSMD3 DDX1 CFTR	2.89e-04	115	33	3	C1510472
Disease	Substance Dependence	CSMD3 DDX1 CFTR	2.89e-04	115	33	3	C0038580
Disease	Substance Use Disorders	CSMD3 DDX1 CFTR	2.89e-04	115	33	3	C0038586
Disease	Organic Mental Disorders, Substance-Induced	CSMD3 DDX1 CFTR	2.89e-04	115	33	3	C0029231
Disease	Prescription Drug Abuse	CSMD3 DDX1 CFTR	2.89e-04	115	33	3	C4316881
Disease	Substance abuse problem	CSMD3 DDX1 CFTR	2.96e-04	116	33	3	C0740858
Disease	response to TNF antagonist, joint damage measurement	NAV2 CSMD3	3.58e-04	25	33	2	EFO_0004653, EFO_0005413
Disease	Craniofacial Abnormalities	SIN3A FGFR2 B3GAT3	7.04e-04	156	33	3	C0376634

Protein segments in the cluster

Peptide	Gene	Start	Entry
KRAKHKINPVWNEMI	SYT13	346	Q7L8C5
PWKITEMSTKRHKRQ	nan	536	A8MVM7
PQIWEKIHEMVKKNS	ACSBG2	321	Q5FVE4
VWHTRTEKPKMKQEE	B3GAT3	306	O94766
MIIENSHVKKDDIWP	CFTR	1191	P13569
VPAHASVKKMKEENW	CSMD3	3561	Q7Z407
QWHVKTMKFRDRPVK	BRWD3	296	Q6RI45
WTNTEKMEKRLHAVP	FGFR2	156	P21802
TMERSQKPKQKHNRW	MAP7	146	Q14244
VHEQLSKKSQKWDEM	PPP1R2P1	36	Q96PQ5
KKLSEKIMHFPTWVD	DDX1	416	Q92499
KKNKPEWREEQMASI	ING3	51	Q9NXR8
ENKKITDPDVVHIWK	PLXNC1	1396	O60486
KKRHVDPFMEWTQII	MED12	176	Q93074
EKKMWRQEEKIHEQE	GOLGA6L1	436	Q8N7Z2
EIWRQKEKMHEQEKI	GOLGA6L1	476	Q8N7Z2
RKQEEKVWRQEEKMH	GOLGA6L1	491	Q8N7Z2
KVWRQEEKMHDQEEK	GOLGA6L1	496	Q8N7Z2
KMWRQEEKIHEQEKI	GOLGA6L6	426	A8MZA4
KMHEQEKIWEEEKRQ	GOLGA6L6	526	A8MZA4
KMHEQEKIWEEEKRQ	GOLGA6L22	501	H0YM25
KISKLEQEKEHWMLE	PPP1R21	571	Q6ZMI0
QKWHVVSSKMEERKS	MACF1	6421	Q9UPN3
ERMKQSWKEAPKHIK	HSD17B6	221	O14756
PVIQKMWDQEKDHLK	COQ7	81	Q99807
SRKKDKTWMHTPEAL	GULP1	6	Q9UBP9
SMESEVPPKHKETRW	GCNT3	251	O95395
MDKHGVKTPLWKKET	C17orf50	1	Q8WW18
HKEMSKVWNDLRPKL	SNX8	426	Q9Y5X2
SLPEMIKDWTKEHVK	SAMD9L	6	Q8IVG5
HVKIVVSFQEEMKWK	NAV2	2016	Q8IVL1
KWTKEHVPREMAAET	SIN3A	1216	Q96ST3
MWKRSDHQPKIKAED	SCP2D1	1	Q9UJQ7
KKVTMLRPKEDENSW	MRE11	196	P49959
KHMKETFQLIWEKET	NLRP9	101	Q7RTR0
WKPMSVKHTEKLERE	VPS13A	2566	Q96RL7
DQDKVHMWEQTVKKD	SMC1A	831	Q14683
HSPSRKMTVKEQQEW	SNW1	231	Q13573
KMKFITEIWHPNVDK	UBE2G1	71	P62253
IKPRSHTVWEKENVK	MYOM1	281	P52179
PKITWMKNKVAIVDD	MYBPC1	1076	Q00872
EKWNKDKTTIHVMPD	NEB	1751	P20929
AWEADKTKVHIMPDI	NEB	1996	P20929
WNKDKTKIHVMPDTP	NEB	2241	P20929
AWDKDKTTVHIMPDT	NEB	2726	P20929
VWDKDKTSIHIMPDT	NEB	3941	P20929